BioWraptor raises $1.5M to kill the vaccine cold chain
What's the deal? BioWraptorDealroom has a profile for this one. Try Dealroom →, a New York biotech stabilizing fragile biomolecules at room temperature, has closed a $1.5 million pre-seed round. Backers include Anima x Alpha Star, SNOCAP, and NY Ventures, plus angel investors Pascal and Bérangère Marguet, Ryan Jeffery, and Dolgin and Greg Haar.
What's the endgame? The company has engineered naturally derived building blocks that form a protective "wrap" around fragile biomolecules, drawing inspiration from tardigrades — microscopic organisms that survive extreme conditions. By cutting the need for refrigeration, it aims to simplify distribution and expand access to medicines, diagnostics, and research tools.
Why it matters? "From the -80°Celsius freezer to the refrigerated truck to the fridge in someone's kitchen, the entire logistics chain for many healthcare products, including life-saving vaccines, relies on refrigeration," said chief executive officer Maëva Coste. "This is expensive, wasteful, energy-consuming, and access-restricting." BioWraptor's work builds on research published by Coste and a City University of New York team in Nature Materials.
Where the money goes? The funding will expand laboratory resourcing to accelerate customer pilots and commercialization in the life sciences. The platform also has potential uses in agriculture, cosmetics, and space.
Why now? Interest in cold-chain alternatives is climbing. In September, the US Advanced Research Projects Agency for Health committed up to $87 million over four years toward room-temperature storage for cell-based medicines — an adjacent effort, since that program targets living cell therapies while BioWraptor focuses on peptide-based stabilization.
What could go wrong? The $1.5 million raise is modest. The real test is whether the technology preserves activity and shelf life across real products, and whether it can scale commercially.
The signal: Refrigeration is one of the biggest hidden costs in moving perishable goods. "As it scales, this innovation could lower costs for essentials from groceries to pharmaceuticals while reducing energy demand," said Jonathan Azoff, co-founder and general partner at SNOCAP — a bet that removing the fridge could reshape how healthcare reaches the world.
Read more: einpresswire.com
Image credit: Generated with Gemini
